Homeless Overdose Prevention- Expansion
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT07716202
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Homelessness
- Opioid Education and Naloxone Distribution (OEND)
- Substance Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Homeless Overdose Prevention- Expansion (HOPE) - Low Intensity — BEHAVIORALHomeless Overdose Prevention - Expansion (HOPE) tests implementation of overdose education and naloxone distribution (OEND), a program that targets homeless experienced Veterans at risk for overdose, including Veterans in community-based supportive housing. During pre-implementation, investigators will conduct a rapid qualitative evaluation with 5-10 key informants at each of the identified implementation sites to refine the implementation approach. Investigators will evaluate low-intensity (LI) vs high-intensity (HI) strategy. The LI implementation approach will include providing sites with the HOPE Implementation Playbook, including access to the associated resources on the HOPE SharePoint site.
- Homeless Overdose Prevention- Expansion (HOPE) - High Intensity — BEHAVIORALHomeless Overdose Prevention - Expansion (HOPE) tests implementation of overdose education and naloxone distribution (OEND), a program that targets homeless experienced Veterans at risk for overdose, including Veterans in community-based supportive housing. During pre-implementation, investigators will conduct a rapid qualitative evaluation with 5-10 key informants at each of the identified implementation sites to refine the implementation approach. Investigators will evaluate low-intensity (LI) vs high-intensity (HI) strategy. The HI approach includes: (1) creation of a novel clinical team if not created under LI; (2) monthly overdose education and training delivered synchronously via Microsoft Teams; (3) monthly audit and feedback for each HUD-VASH team on progress toward providing OEND; and (4) technical assistance.
Study Details
Homeless Overdose Prevention - Expansion (HOPE), tests implementation of overdose education and naloxone distribution (OEND), a program that targets homeless experienced Veterans at risk for overdose, including Veterans in community-based supportive housing. HOPE sites will receive a playbook that offers step-by-step instructions, tools, templates, and checklists tailorable to site needs; sites will also receive performance feedback about their performance relative to a standard or benchmark.
Key Dates
- First listed
- Jul 21, 2026
- Start date
- Jul 31, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 31, 2030
- Completion
- Sep 30, 2030
Study Design
- Enrollment
- 1,200 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Low-Intensity (LI)The LI implementation approach will include providing sites with the HOPE Implementation Playbook, including access to the associated resources (e.g., OEND note templates) on the HOPE SharePoint site. Investigators will begin with an initial training session with each site, and lead a monthly learning collaborative for 6 months. The LI phase will allow evaluation of the effect of a comprehensive playbook on uptake of OEND.
- Active Comparator: High-Intensity (HI)The HI approach will include: (1) creation of a novel clinical team (i.e., prescriber and HUD-VASH team) if not created under LI; (2) monthly overdose education and training delivered synchronously via Microsoft Teams; (3) monthly audit and feedback for each HUD-VASH team on progress toward providing OEND; and (4) technical assistance. Investigators hypothesize the HI implementation strategy will have a greater impact on RE-AIM outcomes.
Primary Outcome Measure
Reach - VA administrative data [ Time Frame: 12 months ]
Central Contacts
- Amanda M Midboe, PhD(650) 493-5000
- Madeleine C Golding, MPH BA(650) 614-9997
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Palo Alto Health Care System, Palo Alto, CA | Palo Alto | California | 94304-1207 | - |
Find similar trials in Palo Alto, CA
Related Studies
- OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment UnitRecruiting · VA Office of Research and Development · San Diego, California
- Housing Transitions QUERIPHASE1 · Enrolling By Invitation · VA Office of Research and Development · West Los Angeles, California
- MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMIRecruiting · VA Office of Research and Development · West Los Angeles, California
- Smoking Cessation CM for Veterans With or at Risk for CancerRecruiting · VA Office of Research and Development · San Francisco, California